SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/04/23 YIELD10 Bioscience, Inc. 424B5 1:924K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 424B5 Prospectus - Primary Offering or Shelf Securities HTML 325K - New Facts or Events
tm2312186-1_424b5 - none - 5.1719021s |
| | |
Per Share
|
| |
Total
|
| ||||||
Offering price
|
| | | $ | 2.98 | | | | | $ | 2,999,995.80 | | |
Placement Agent fees(1)
|
| | | $ | 0.14 | | | | | $ | 139,999.80 | | |
Proceeds, before expenses, to Yield10 Bioscience
|
| | | $ | 2.84 | | | | | $ | 2,859,996.00 | | |
| | |
Page
|
| |||
| | | | S-1 | | | |
| | | | S-1 | | | |
| | | | S-3 | | | |
| | | | S-6 | | | |
| | | | S-8 | | | |
| | | | S-11 | | | |
| | | | S-12 | | | |
| | | | S-13 | | | |
| | | | S-15 | | | |
| | | | S-17 | | | |
| | | | S-20 | | | |
| | | | S-20 | | | |
| | | | S-21 | | | |
| | | | S-21 | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 10 | | | |
| | | | | 11 | | | |
| | | | | 11 | | | |
| | | | | 13 | | | |
| | | | | 14 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | 15 | | |
|
Offering price
|
| |
|
| | | $ | 2.98 | | | |||
|
Net tangible book value per share as of December 31, 2022
|
| | | $ | 0.88 | | | | |||||
|
Increase in net tangible book value per share attributable to new investors
|
| | | $ | 0.32 | | | | |||||
|
Adjusted net tangible book value per share after giving effect to the offering
|
| | | | | | | | | $ | 1.20 | | |
|
Dilution per share to new investors in this offering
|
| | | | | | | | | $ | 1.78 | | |
| | |
Per Share
|
| |
Per Pre-Funded
Warrant Underlying Share |
| |
Total
|
| |||||||||
Offering price
|
| | | $ | 2.98 | | | | | $ | 2.9799 | | | | | $ | 2,999,995.80 | | |
Placement agent fees(1)
|
| | | $ | 0.12 | | | | | $ | 0.02 | | | | | $ | 139,999.80 | | |
Proceeds to us, before expenses
|
| | | $ | 2.86 | | | | | $ | 2.9599 | | | | | $ | 2,859,996.00 | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 10 | | | |
| | | | | 11 | | | |
| | | | | 11 | | | |
| | | | | 13 | | | |
| | | | | 14 | | | |
| | | | | 14 | | | |
| | | | | 15 | | | |
| | | | | 15 | | |
This ‘424B5’ Filing | Date | Other Filings | ||
---|---|---|---|---|
5/19/27 | ||||
9/11/24 | ||||
1/7/24 | ||||
12/31/23 | ||||
5/5/23 | ||||
Filed on: | 5/4/23 | 8-K | ||
5/3/23 | 8-K | |||
4/11/23 | ||||
12/31/22 | 10-K, 4 | |||
12/31/21 | 10-K, 4 | |||
4/2/21 | 4, EFFECT | |||
3/29/21 | DEF 14A, S-3, S-8 | |||
3/26/21 | ||||
3/12/21 | ||||
12/31/20 | 10-K, 4 | |||
12/31/19 | 10-K | |||
1/7/18 | ||||
9/12/17 | ||||
7/3/17 | 4, 8-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/04/23 YIELD10 Bioscience, Inc. 8-K:1,3,8,9 5/03/23 15:921K Toppan Merrill/FA 5/03/23 YIELD10 Bioscience, Inc. 8-K:1 5/03/23 10:182K Toppan Merrill/FA 5/01/23 YIELD10 Bioscience, Inc. 8-K:1,2,9 4/27/23 12:466K 4/06/23 YIELD10 Bioscience, Inc. DEF 14A 4/05/23 1:832K 3/14/23 YIELD10 Bioscience, Inc. 10-K 12/31/22 82:8.3M 1/24/23 YIELD10 Bioscience, Inc. 8-K:1,9 1/23/23 12:491K Toppan Merrill/FA 3/29/21 YIELD10 Bioscience, Inc. DEF 14A 3/29/21 1:634K 3/16/21 YIELD10 Bioscience, Inc. 10-K 12/31/20 84:9.1M 2/02/21 YIELD10 Bioscience, Inc. 8-K:1,8,9 1/31/21 4:284K Toppan Merrill/FA 1/19/21 YIELD10 Bioscience, Inc. 8-K:8 1/19/21 2:69K 11/06/06 YIELD10 Bioscience, Inc. 8-A12B 11/03/06 1:22K Toppan Merrill/FA |